News

Evusheld Monoclonal Antibody Combination Now Available in Malaysia’s Private Market for Prevention of COVID-19 in High-Risk Individuals

AstraZeneca’s Evusheld (tixagevimab and cilgavimab, MAL 22056042ACR2), a monoclonal antibody combination, has been launched today in Malaysia’s private hospitals for...

High-Impact Ideas on the Improvement of Public Health will be Introduced Through the Selangor Health Partnership Program 2023 (SELHEP2023)

The Selangor State Government will implement new ideas in public health interventions through the Selangor Health Partnership Program 2023 (SELHEP2023)....